InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IFRX InflaRx N.V.

盘前交易 11-19 05:36:08 EST

1.74

-0.21

-10.77%

最高2.02	最低1.51	成交量43.87万
今开1.94	昨收1.95	日振幅26.06%
总市值1.02亿	流通市值8,496万	总股本5,888万
成交额78.94万	换手率0.90%	流通股本4,883万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":1.74,"timestamp":1731963600000,"preClose":1.95,"halted":0,"volume":438733,"delay":0,"floatShares":48826874,"shares":58883272,"eps":-1.07706,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.21,"latestTime":"11-19 05:36:08 EST","open":1.94,"high":2.0182,"low":1.51,"amount":789356.2168226,"amplitude":0.260615,"askPrice":1.98,"askSize":100,"bidPrice":1.6,"bidSize":28000,"shortable":0,"etf":0,"ttmEps":-1.07706,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732026600000},"adr":0,"listingDate":1510117200000,"adjPreClose":1.74,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.74,"latestTime":"19:51 EST","volume":770,"amount":1275.16,"timestamp":1731977469712},"volumeRatio":0.6812686010075549,"impliedVol":0.8528,"impliedVolPercentile":0.0159},"requestUrl":"/m/hq/s/IFRX","defaultTab":"news","newsList":[{"id":"2484510679","title":"Inflarx N.V.盘中异动 早盘急速下跌7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484510679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484510679?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:49","pubTimestamp":1731941345,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时49分，Inflarx N.V.股票出现异动，股价急速下跌7.69%。截至发稿，该股报1.80美元/股，成交量4.2877万股，换手率0.07%，振幅7.60%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.28%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224905971a72fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224905971a72fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2483370399","title":"Inflarx N.V.盘中异动 股价大涨14.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483370399?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681105,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Inflarx N.V.股票出现波动，股价快速上涨14.78%。截至发稿，该股报2.33美元/股，成交量20.0769万股，换手率0.34%，振幅8.37%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.69%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223145abc4e6e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223145abc4e6e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2483465801","title":"Inflarx N.V.盘中异动 大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483465801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483465801?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:40","pubTimestamp":1731595251,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时40分，Inflarx N.V.股票出现波动，股价急速上涨5.26%。截至发稿，该股报1.80美元/股，成交量3.4407万股，换手率0.06%，振幅3.94%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.31%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224051abc15fca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224051abc15fca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","IFRX","ELAB","BK4139"],"gpt_icon":0},{"id":"2483889275","title":"Inflarx N.V.盘中异动 快速拉升5.30%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483889275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483889275?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:34","pubTimestamp":1731508440,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时34分，Inflarx N.V.股票出现波动，股价急速拉升5.30%。截至发稿，该股报1.59美元/股，成交量1.3486万股，换手率0.02%，振幅2.65%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.07%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322340098e425b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322340098e425b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2481986407","title":"Inflarx N.V.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481986407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481986407?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:55","pubTimestamp":1730904917,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时55分，Inflarx N.V.股票出现波动，股价大幅下跌5.00%。截至发稿，该股报1.52美元/股，成交量1133股，换手率0.00%，振幅3.01%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.83%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106225517a21d3802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106225517a21d3802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2480057957","title":"Inflarx N.V.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480057957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480057957?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:20","pubTimestamp":1730398820,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时20分，Inflarx N.V.股票出现波动，股价急速下跌5.10%。截至发稿，该股报1.49美元/股，成交量5.876万股，换手率0.10%，振幅5.75%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为3.56%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101022020ab8cd5c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101022020ab8cd5c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2478614066","title":"Inflarx N.V.盘中异动 股价大涨6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478614066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478614066?lang=zh_cn&edition=full","pubTime":"2024-10-25 02:52","pubTimestamp":1729795963,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日02时52分，Inflarx N.V.股票出现波动，股价大幅拉升6.71%。截至发稿，该股报1.59美元/股，成交量7.4683万股，换手率0.13%，振幅6.38%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.21%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025025244971a2215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025025244971a2215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2477364629","title":"Inflarx N.V.盘中异动 快速跳水5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477364629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477364629?lang=zh_cn&edition=full","pubTime":"2024-10-23 02:44","pubTimestamp":1729622666,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日02时44分，Inflarx N.V.股票出现波动，股价大幅跳水5.23%。截至发稿，该股报1.45美元/股，成交量2.7574万股，换手率0.05%，振幅3.27%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.93%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102302442798e3dd31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102302442798e3dd31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2477698268","title":"Inflarx N.V.盘中异动 早盘急速下挫7.55%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477698268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477698268?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:14","pubTimestamp":1729520091,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时14分，Inflarx N.V.股票出现异动，股价急速下挫7.55%。截至发稿，该股报1.47美元/股，成交量6372股，换手率0.01%，振幅1.26%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.07%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122145198e3d8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122145198e3d8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2476117153","title":"Inflarx N.V.盘中异动 早盘大幅上涨5.30%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476117153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476117153?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:17","pubTimestamp":1729174630,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时17分，Inflarx N.V.股票出现异动，股价急速拉升5.30%。截至发稿，该股报1.59美元/股，成交量1.6995万股，换手率0.03%，振幅2.98%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.70%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101722171198e3d069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101722171198e3d069&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2475191783","title":"Inflarx N.V.盘中异动 急速跳水5.30%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475191783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475191783?lang=zh_cn&edition=full","pubTime":"2024-10-15 02:22","pubTimestamp":1728930132,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日02时22分，Inflarx N.V.股票出现异动，股价快速跳水5.30%。截至发稿，该股报1.43美元/股，成交量3.6622万股，换手率0.06%，振幅4.34%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.11%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101502221298e3c540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101502221298e3c540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2473481327","title":"Inflarx N.V.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473481327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473481327?lang=zh_cn&edition=full","pubTime":"2024-10-08 01:45","pubTimestamp":1728323145,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日01时45分，Inflarx N.V.股票出现异动，股价大幅下跌5.12%。截至发稿，该股报1.48美元/股，成交量3.978万股，换手率0.07%，振幅5.77%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.07%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080145459719eb31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080145459719eb31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2472026526","title":"Inflarx N.V.盘中异动 股价大跌8.61%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472026526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472026526?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:49","pubTimestamp":1727876982,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时49分，Inflarx N.V.股票出现波动，股价大幅下跌8.61%。截至发稿，该股报1.38美元/股，成交量6891股，换手率0.01%，振幅1.74%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.80%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002214943ab677610&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002214943ab677610&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2469149407","title":"Inflarx N.V.盘中异动 早盘股价大涨5.36%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469149407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469149407?lang=zh_cn&edition=full","pubTime":"2024-09-24 22:04","pubTimestamp":1727186698,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日22时04分，Inflarx N.V.股票出现异动，股价大幅上涨5.36%。截至发稿，该股报1.56美元/股，成交量724股，换手率0.00%，振幅0.00%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为1.36%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924220458a1dc38b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924220458a1dc38b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2469143272","title":"Inflarx N.V.盘中异动 快速跳水5.81%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469143272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469143272?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:39","pubTimestamp":1727102358,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时39分，Inflarx N.V.股票出现波动，股价快速跳水5.81%。截至发稿，该股报1.46美元/股，成交量6077股，换手率0.01%，振幅5.81%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.31%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092322391898e38756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092322391898e38756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2468685034","title":"Inflarx N.V.盘中异动 下午盘股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468685034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468685034?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:06","pubTimestamp":1726769211,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时06分，Inflarx N.V.股票出现异动，股价大幅拉升5.52%。截至发稿，该股报1.53美元/股，成交量5.9595万股，换手率0.10%，振幅6.21%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.38%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092002065298e38268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092002065298e38268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2461882491","title":"Inflarx N.V.盘中异动 大幅上涨6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461882491","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461882491?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:22","pubTimestamp":1724174522,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时22分，Inflarx N.V.股票出现异动，股价快速拉升6.52%。截至发稿，该股报1.47美元/股，成交量3.2347万股，换手率0.05%，振幅3.87%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.18%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408210122029719959e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408210122029719959e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2460735704","title":"Inflarx N.V.2024财年第二财季实现净利润-14.91百万美元，同比减少66.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460735704","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460735704?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910648,"startTime":"0","endTime":"0","summary":"8月18日，Inflarx N.V.公布财报，公告显示公司2024财年第二财季净利润为-14.91百万美元，同比减少66.97%；其中营业收入为6843.55美元，每股基本收益为-0.25美元。从资产负债表来看，Inflarx N.V.总负债11.66百万美元，其中短期债务425993.83美元，资产负债比为8.56，流动比率为8.92。机构评级：截至2024年8月18日，当前有4家机构对Inflarx N.V.目标价做出预测，其中目标均价为7.81美元，其中最低目标价为5.03美元，最高目标价为11.09美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800062995a167a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800062995a167a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX"],"gpt_icon":0},{"id":"2459214042","title":"Inflarx N.V.盘中异动 早盘股价大跌5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459214042","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459214042?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:30","pubTimestamp":1723815038,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时30分，Inflarx N.V.股票出现波动，股价急速下跌5.93%。截至发稿，该股报1.27美元/股，成交量1股，换手率0.00%，振幅0.00%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621303898e352a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621303898e352a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2459471552","title":"Inflarx N.V.盘中异动 急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459471552","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459471552?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:17","pubTimestamp":1723735021,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时17分，Inflarx N.V.股票出现异动，股价大幅下跌5.19%。截至发稿，该股报1.28美元/股，成交量2.4163万股，换手率0.04%，振幅5.93%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.23%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523170198e350f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081523170198e350f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inflarx.com","stockEarnings":[{"period":"1week","weight":0.1373},{"period":"1month","weight":0.0943},{"period":"3month","weight":0.1837},{"period":"6month","weight":0.0675},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0675}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"InflaRx N.V.于2017年6月根据荷兰法律成立，根据公司重组的条款，该公司是一家InflaRx GmbH的控股的公司。该公司是一家临床阶段的生物制药公司，专注于应用其独有的反C5a技术来发现和开发一种名为C5a的补充激活因子的一级、有效和特异性抑制剂。C5a是一种强大的炎症介质，涉及多种自身免疫和其他炎症疾病的进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.090583},{"month":2,"riseRate":0.571429,"avgChangeRate":0.006427},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.068353},{"month":4,"riseRate":0.571429,"avgChangeRate":0.389384},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.049969},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.19704},{"month":7,"riseRate":0.285714,"avgChangeRate":0.078748},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.037266},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.033335},{"month":10,"riseRate":0.428571,"avgChangeRate":0.015702},{"month":11,"riseRate":0.571429,"avgChangeRate":0.053518},{"month":12,"riseRate":0.714286,"avgChangeRate":0.137243}],"exchange":"NASDAQ","name":"InflaRx N.V.","nameEN":"InflaRx N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"InflaRx N.V.,IFRX,InflaRx N.V.股票,InflaRx N.V.股票老虎,InflaRx N.V.股票老虎国际,InflaRx N.V.行情,InflaRx N.V.股票行情,InflaRx N.V.股价,InflaRx N.V.股市,InflaRx N.V.股票价格,InflaRx N.V.股票交易,InflaRx N.V.股票购买,InflaRx N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}